1. Home
  2. SHPH vs NXTT Comparison

SHPH vs NXTT Comparison

Compare SHPH & NXTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SHPH
  • NXTT
  • Stock Information
  • Founded
  • SHPH 2012
  • NXTT 2019
  • Country
  • SHPH United States
  • NXTT China
  • Employees
  • SHPH N/A
  • NXTT N/A
  • Industry
  • SHPH Biotechnology: Pharmaceutical Preparations
  • NXTT
  • Sector
  • SHPH Health Care
  • NXTT
  • Exchange
  • SHPH Nasdaq
  • NXTT NYSE
  • Market Cap
  • SHPH 2.3M
  • NXTT 1.9M
  • IPO Year
  • SHPH 2022
  • NXTT N/A
  • Fundamental
  • Price
  • SHPH $0.17
  • NXTT $1.91
  • Analyst Decision
  • SHPH
  • NXTT
  • Analyst Count
  • SHPH 0
  • NXTT 0
  • Target Price
  • SHPH N/A
  • NXTT N/A
  • AVG Volume (30 Days)
  • SHPH 12.3M
  • NXTT 16.7M
  • Earning Date
  • SHPH 05-08-2025
  • NXTT 05-09-2025
  • Dividend Yield
  • SHPH N/A
  • NXTT N/A
  • EPS Growth
  • SHPH N/A
  • NXTT 21.23
  • EPS
  • SHPH N/A
  • NXTT 6.62
  • Revenue
  • SHPH N/A
  • NXTT $1,800,000.00
  • Revenue This Year
  • SHPH N/A
  • NXTT N/A
  • Revenue Next Year
  • SHPH N/A
  • NXTT N/A
  • P/E Ratio
  • SHPH N/A
  • NXTT $0.29
  • Revenue Growth
  • SHPH N/A
  • NXTT N/A
  • 52 Week Low
  • SHPH $0.16
  • NXTT $0.22
  • 52 Week High
  • SHPH $4.71
  • NXTT $6.00
  • Technical
  • Relative Strength Index (RSI)
  • SHPH 30.47
  • NXTT 55.67
  • Support Level
  • SHPH $0.16
  • NXTT $2.06
  • Resistance Level
  • SHPH $0.18
  • NXTT $2.89
  • Average True Range (ATR)
  • SHPH 0.02
  • NXTT 0.67
  • MACD
  • SHPH 0.00
  • NXTT -0.05
  • Stochastic Oscillator
  • SHPH 10.19
  • NXTT 11.62

About SHPH Shuttle Pharmaceuticals Holdings Inc.

Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.

About NXTT NEXT TECHNOLOGY HOLDING INC

Next Technology Holding Inc pursues two corporate strategies. One business strategy is to continue providing software development services, and the other strategy is to acquire and hold Bitcoin. It provides AI-enabled software development services to its customers, which include developing, designing, and implementing various SAAS software solutions for businesses of all types, including industrial and other businesses. Its bitcoin acquisition strategy generally involves acquiring bitcoin with its liquid assets that exceed working capital requirements, and from time to time, subject to market conditions, issuing debt or equity securities or engaging in other capital raising transactions to use the proceeds to purchase bitcoin.

Share on Social Networks: